41738944731066417062948583932.381.525.073.990001410428--12-312023Q3false41616134174381P12Y0.050.050.050.050.050001410428us-gaap:CommonStockMember2022-04-012022-06-300001410428xwel:ShareRepurchaseProgramMember2022-05-012022-05-310001410428srt:MinimumMemberus-gaap:WarrantMember2022-12-310001410428srt:MaximumMemberus-gaap:WarrantMember2022-12-310001410428srt:MinimumMemberus-gaap:WarrantMember2023-01-012023-09-300001410428srt:MaximumMemberus-gaap:WarrantMember2023-01-012023-09-300001410428xwel:DirectorsEmployeesAndConsultantsMemberxwel:XpresTest2020EquityIncentivePlanMember2020-09-012020-09-300001410428xwel:XprestestMember2022-09-300001410428xwel:XpresspaMember2022-09-300001410428xwel:TreattmMember2022-09-300001410428us-gaap:CorporateAndOtherMember2022-09-300001410428us-gaap:NonUsMemberxwel:SchipholAmsterdamAirportMember2023-09-300001410428us-gaap:NonUsMemberxwel:IstanbulAirportMember2023-09-300001410428us-gaap:NonUsMemberxwel:DubaiInternationalAirportMember2023-09-300001410428country:USxwel:XpresspaMember2023-09-300001410428xwel:NaplesWaxLlcMember2023-09-300001410428xwel:XpresspaMemberxwel:AustinBergstromInternationalAirportMember2022-01-012022-12-3100014104282020-09-300001410428us-gaap:NonUsMemberxwel:XpresspaMember2023-09-300001410428xwel:NaplesWaxLlcMember2023-09-120001410428us-gaap:AccountsReceivableMemberxwel:HyperPointeSegmentMember2023-09-300001410428us-gaap:AccountsReceivableMemberxwel:HyperPointeSegmentMember2022-12-310001410428xwel:ShareRepurchaseProgramMember2021-08-310001410428us-gaap:TreasuryStockCommonMember2022-07-012022-09-300001410428us-gaap:CommonStockMember2022-07-012022-09-300001410428us-gaap:TreasuryStockCommonMember2022-04-012022-06-300001410428xwel:ShareRepurchaseProgramMember2022-08-032022-08-030001410428xwel:ShareRepurchaseProgramMember2022-01-012022-09-300001410428us-gaap:CommonStockMember2023-07-012023-09-300001410428us-gaap:CommonStockMember2023-04-012023-06-300001410428us-gaap:CommonStockMember2023-01-012023-03-310001410428us-gaap:CommonStockMember2022-01-012022-03-3100014104282023-09-282023-09-280001410428us-gaap:RetainedEarningsMember2023-09-300001410428us-gaap:ParentMember2023-09-300001410428us-gaap:NoncontrollingInterestMember2023-09-300001410428us-gaap:AdditionalPaidInCapitalMember2023-09-300001410428us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300001410428us-gaap:RetainedEarningsMember2023-06-300001410428us-gaap:ParentMember2023-06-300001410428us-gaap:NoncontrollingInterestMember2023-06-300001410428us-gaap:AdditionalPaidInCapitalMember2023-06-300001410428us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-3000014104282023-06-300001410428us-gaap:RetainedEarningsMember2023-03-310001410428us-gaap:ParentMember2023-03-310001410428us-gaap:NoncontrollingInterestMember2023-03-310001410428us-gaap:AdditionalPaidInCapitalMember2023-03-310001410428us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-3100014104282023-03-310001410428us-gaap:RetainedEarningsMember2022-12-310001410428us-gaap:ParentMember2022-12-310001410428us-gaap:NoncontrollingInterestMember2022-12-310001410428us-gaap:AdditionalPaidInCapitalMember2022-12-310001410428us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001410428us-gaap:RetainedEarningsMember2022-09-300001410428us-gaap:ParentMember2022-09-300001410428us-gaap:NoncontrollingInterestMember2022-09-300001410428us-gaap:AdditionalPaidInCapitalMember2022-09-300001410428us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-09-300001410428us-gaap:TreasuryStockCommonMember2022-06-300001410428us-gaap:RetainedEarningsMember2022-06-300001410428us-gaap:ParentMember2022-06-300001410428us-gaap:NoncontrollingInterestMember2022-06-300001410428us-gaap:AdditionalPaidInCapitalMember2022-06-300001410428us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-3000014104282022-06-300001410428us-gaap:RetainedEarningsMember2022-03-310001410428us-gaap:ParentMember2022-03-310001410428us-gaap:NoncontrollingInterestMember2022-03-310001410428us-gaap:AdditionalPaidInCapitalMember2022-03-310001410428us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-3100014104282022-03-310001410428us-gaap:RetainedEarningsMember2021-12-310001410428us-gaap:ParentMember2021-12-310001410428us-gaap:NoncontrollingInterestMember2021-12-310001410428us-gaap:AdditionalPaidInCapitalMember2021-12-310001410428us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001410428srt:MinimumMember2023-01-012023-09-300001410428srt:MaximumMember2023-01-012023-09-300001410428srt:MaximumMemberxwel:EquityIncentivePlan2020Member2023-01-012023-09-300001410428srt:MinimumMember2022-12-310001410428srt:MaximumMember2022-12-310001410428us-gaap:RestrictedStockUnitsRSUMember2023-09-300001410428us-gaap:RestrictedStockUnitsRSUMember2022-12-310001410428us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300001410428srt:MinimumMember2023-09-300001410428srt:MaximumMember2023-09-300001410428xwel:EquityIncentivePlan2020Member2023-09-300001410428srt:MaximumMemberxwel:DirectorsEmployeesAndConsultantsMemberxwel:XpresTest2020EquityIncentivePlanMember2020-09-300001410428srt:MaximumMemberxwel:EquityIncentivePlan2020Member2020-09-300001410428xwel:EquityIncentivePlan2020Member2022-10-042022-10-040001410428srt:MinimumMemberus-gaap:EmployeeStockOptionMember2023-01-012023-09-300001410428srt:MaximumMemberus-gaap:EmployeeStockOptionMember2023-01-012023-09-300001410428us-gaap:EmployeeStockOptionMember2023-01-012023-09-300001410428srt:MinimumMemberus-gaap:EmployeeStockOptionMember2023-09-300001410428srt:MaximumMemberus-gaap:EmployeeStockOptionMember2023-09-300001410428us-gaap:WarrantMember2023-09-300001410428us-gaap:WarrantMember2022-12-310001410428us-gaap:StockCompensationPlanMember2020-09-012020-09-300001410428xwel:XprestestMemberxwel:CdcProgramOptionsAndPublicHealthServicesMember2023-07-012023-09-300001410428us-gaap:ServiceMember2023-07-012023-09-300001410428us-gaap:ProductMember2023-07-012023-09-300001410428us-gaap:ProductAndServiceOtherMember2023-07-012023-09-300001410428xwel:XprestestMemberxwel:CdcProgramOptionsAndPublicHealthServicesMember2023-01-012023-09-300001410428us-gaap:ServiceMember2023-01-012023-09-300001410428us-gaap:ProductMember2023-01-012023-09-300001410428us-gaap:ProductAndServiceOtherMember2023-01-012023-09-300001410428us-gaap:HealthCarePatientServiceMember2023-01-012023-09-300001410428us-gaap:ServiceMember2022-07-012022-09-300001410428us-gaap:ProductMember2022-07-012022-09-300001410428us-gaap:ProductAndServiceOtherMember2022-07-012022-09-300001410428us-gaap:HealthCarePatientServiceMember2022-07-012022-09-300001410428us-gaap:ServiceMember2022-01-012022-09-300001410428us-gaap:ProductMember2022-01-012022-09-300001410428us-gaap:ProductAndServiceOtherMember2022-01-012022-09-300001410428us-gaap:HealthCarePatientServiceMember2022-01-012022-09-300001410428us-gaap:RetainedEarningsMember2023-07-012023-09-300001410428us-gaap:RetainedEarningsMember2023-04-012023-06-300001410428us-gaap:RetainedEarningsMember2023-01-012023-03-310001410428us-gaap:RetainedEarningsMember2022-07-012022-09-300001410428us-gaap:RetainedEarningsMember2022-04-012022-06-300001410428us-gaap:RetainedEarningsMember2022-01-012022-03-310001410428xwel:NaplesWaxLlcMember2023-01-012023-09-300001410428xwel:GcgConnectLlcDBAHyperpointeMember2022-01-012022-09-300001410428us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300001410428us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012023-06-300001410428us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310001410428us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-012022-09-300001410428us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-012022-06-300001410428us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310001410428us-gaap:NoncontrollingInterestMember2022-01-012022-03-310001410428xwel:TgManagementPhlbbMembersrt:MinimumMember2023-01-012023-09-300001410428xwel:TgManagementPhlbbMembersrt:MaximumMember2023-01-012023-09-300001410428xwel:AccruedExpensesAndOtherMember2023-09-300001410428xwel:AccruedExpensesAndOtherMember2022-12-310001410428xwel:TgManagementPhlbbMember2023-09-300001410428us-gaap:ForeignCurrencyGainLossMember2023-07-012023-09-300001410428us-gaap:ForeignCurrencyGainLossMember2023-01-012023-09-300001410428us-gaap:ForeignCurrencyGainLossMember2022-07-012022-09-300001410428us-gaap:ForeignCurrencyGainLossMember2022-01-012022-09-300001410428us-gaap:LicenseMember2023-09-300001410428us-gaap:CustomerRelationshipsMember2023-09-300001410428us-gaap:ComputerSoftwareIntangibleAssetMember2023-09-300001410428us-gaap:TradeNamesMember2022-12-310001410428us-gaap:LicenseMember2022-12-310001410428us-gaap:CustomerRelationshipsMember2022-12-310001410428us-gaap:ComputerSoftwareIntangibleAssetMember2022-12-310001410428us-gaap:RestrictedStockUnitsRSUMemberxwel:XpresTest2020EquityIncentivePlanMember2023-09-300001410428xwel:XprestestMember2023-07-012023-09-300001410428xwel:XpresspaMember2023-07-012023-09-300001410428xwel:TreattmMember2023-07-012023-09-300001410428us-gaap:CorporateAndOtherMember2023-07-012023-09-300001410428xwel:XprestestMember2023-01-012023-09-300001410428xwel:XpresspaMember2023-01-012023-09-300001410428xwel:TreattmMember2023-01-012023-09-300001410428us-gaap:CorporateAndOtherMember2023-01-012023-09-300001410428xwel:XprestestMember2022-07-012022-09-300001410428xwel:XpresspaMember2022-07-012022-09-300001410428xwel:TreattmMember2022-07-012022-09-300001410428us-gaap:CorporateAndOtherMember2022-07-012022-09-300001410428xwel:XprestestMember2022-01-012022-09-300001410428xwel:XpresspaMember2022-01-012022-09-300001410428xwel:TreattmMember2022-01-012022-09-300001410428us-gaap:CorporateAndOtherMember2022-01-012022-09-300001410428xwel:GcgConnectLlcDBAHyperpointeMemberxwel:HyperPointeSegmentMember2022-01-012022-12-310001410428xwel:GcgConnectLlcDBAHyperpointeMemberxwel:HyperPointeSegmentMember2023-09-300001410428xwel:GcgConnectLlcDBAHyperpointeMemberxwel:HyperPointeSegmentMember2022-12-310001410428xwel:TravelerEnrollmentInitiativesMemberxwel:XprestestMemberxwel:CdcProgramOptionsAndPublicHealthServicesMember2022-09-300001410428xwel:PassengerAndAircraftWastewaterSampleCollectionMemberxwel:XprestestMemberxwel:CdcProgramOptionsAndPublicHealthServicesMember2022-09-300001410428srt:MinimumMemberxwel:XprestestMemberxwel:CdcProgramOptionsAndPublicHealthServicesMember2022-09-300001410428xwel:XprestestMemberxwel:CdcProgramOptionsAndPublicHealthServicesMember2022-09-300001410428xwel:XprestestMemberxwel:CentersForDiseaseControlAndPreventionMember2022-01-310001410428xwel:XprestestMember2023-08-120001410428xwel:XprestestMember2022-08-310001410428us-gaap:CommonStockMember2023-09-300001410428us-gaap:CommonStockMember2023-06-300001410428us-gaap:CommonStockMember2023-03-310001410428us-gaap:CommonStockMember2022-12-310001410428us-gaap:CommonStockMember2022-09-300001410428us-gaap:CommonStockMember2022-06-300001410428us-gaap:CommonStockMember2022-03-310001410428us-gaap:CommonStockMember2021-12-3100014104282022-10-2400014104282022-09-3000014104282021-12-310001410428xwel:NaplesWaxLlcMember2023-09-122023-09-120001410428xwel:XprestestMember2023-09-300001410428xwel:XpresspaMember2023-09-300001410428xwel:TreattmMember2023-09-300001410428us-gaap:CorporateAndOtherMember2023-09-300001410428xwel:XprestestMember2022-12-310001410428xwel:XpresspaMember2022-12-310001410428xwel:TreattmMember2022-12-310001410428us-gaap:CorporateAndOtherMember2022-12-310001410428xwel:VestedAndUnvestedStockOptionMember2023-07-012023-09-300001410428xwel:UnvestedRestrictedStockUnitsMember2023-07-012023-09-300001410428us-gaap:WarrantMember2023-07-012023-09-300001410428xwel:VestedAndUnvestedStockOptionMember2023-01-012023-09-300001410428xwel:UnvestedRestrictedStockUnitsMember2023-01-012023-09-300001410428us-gaap:WarrantMember2023-01-012023-09-300001410428xwel:VestedAndUnvestedStockOptionMember2022-07-012022-09-300001410428xwel:UnvestedRestrictedStockUnitsMember2022-07-012022-09-300001410428us-gaap:WarrantMember2022-07-012022-09-300001410428xwel:VestedAndUnvestedStockOptionMember2022-01-012022-09-300001410428xwel:UnvestedRestrictedStockUnitsMember2022-01-012022-09-300001410428us-gaap:WarrantMember2022-01-012022-09-3000014104282022-01-012022-09-300001410428us-gaap:ParentMember2023-07-012023-09-300001410428us-gaap:NoncontrollingInterestMember2023-07-012023-09-300001410428us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-3000014104282023-07-012023-09-300001410428us-gaap:ParentMember2023-04-012023-06-300001410428us-gaap:NoncontrollingInterestMember2023-04-012023-06-300001410428us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-3000014104282023-04-012023-06-300001410428us-gaap:NoncontrollingInterestMember2023-01-012023-03-310001410428us-gaap:ParentMember2022-07-012022-09-300001410428us-gaap:NoncontrollingInterestMember2022-07-012022-09-300001410428us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-3000014104282022-07-012022-09-300001410428us-gaap:ParentMember2022-04-012022-06-300001410428us-gaap:NoncontrollingInterestMember2022-04-012022-06-300001410428us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-3000014104282022-04-012022-06-300001410428us-gaap:ParentMember2023-01-012023-03-310001410428us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-3100014104282023-01-012023-03-310001410428us-gaap:ParentMember2022-01-012022-03-310001410428us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-3100014104282022-01-012022-03-3100014104282023-09-3000014104282022-12-3100014104282023-11-0900014104282023-01-012023-09-30xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:purexwel:segmentxwel:locationxwel:itemxwel:Center

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2023

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___ to ___

Commission file number: 001-34785

XWELL, Inc.

(Exact Name of Registrant as Specified in its Charter)

Delaware

 

20-4988129

(State or other jurisdiction of
incorporation or organization)

 

(I.R.S. Employer
Identification No.)

 

 

 

254 West 31st Street, 11th Floor, New York, NY

 

10001

(Address of principal executive offices)

 

(Zip Code)

(Registrant’s Telephone Number, Including Area Code): (212) 750-9595

XpresSpa Group, Inc.

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

    

Trading Symbol(s)

    

Name of each exchange on which registered

Common Stock, par value $0.01 per share

 

XWEL

 

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   Yes      No 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes       No  

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes     No  

As of November 9, 2023, 4,179,631 shares of the registrant’s common stock were outstanding.

Table of Contents

XWELL, Inc. and Subsidiaries

Table of Contents

    

Page

PART I. FINANCIAL INFORMATION

3

Item 1.

Condensed Consolidated Financial Statements (Unaudited)

3

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

24

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

31

Item 4.

Controls and Procedures

31

PART II. OTHER INFORMATION

32

Item 1.

Legal Proceedings

32

Item 1A.

Risk Factors

32

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

32

Item 3.

Defaults Upon Senior Securities

32

Item 4.

Mine Safety Disclosures

32

Item 5.

Other Information

32

Item 6.

Exhibits

33

2

Table of Contents

PART I - FINANCIAL INFORMATION

Item 1.Condensed Consolidated Financial Statements (Unaudited)

XWELL, Inc. and Subsidiaries

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(In thousands, except share and per share data)

    

September 30, 

    

December 31, 

2023

2022

Current assets

 

  

 

  

Cash and cash equivalents

$

4,827

$

19,038

Marketable Securities

21,311

23,153

Accounts receivable

1,193

2,858

Inventory

 

968

 

1,161

Other current assets

 

1,663

 

1,122

Total current assets

 

29,962

 

47,332

Restricted cash

 

751

 

751

Property and equipment, net

 

3,801

 

3,666

Intangible assets, net

 

2,174

 

4,008

Operating lease right of use assets, net

 

6,075

 

8,276

Goodwill

-

4,024

Other assets

 

1,787

 

2,369

Total assets

$

44,550

$

70,426

Current liabilities

 

  

 

  

Accounts payable

$

1,511

$

2,312

Accrued expenses and other current liabilities

4,198

5,719

Current portion of operating lease liabilities

2,375

2,586

Deferred revenue

73

339

Total current liabilities

 

8,157

 

10,956

Long-term liabilities

 

 

Operating lease liabilities

 

9,123

 

11,521

Total liabilities

17,280

22,477

Commitments and contingencies (see Note 13)

 

  

 

  

Equity

 

  

 

  

Common Stock, $0.01 par value per share, 150,000,000 shares authorized; 4,174,381 and 4,161,613 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively*

42

42

Additional paid-in capital

 

470,270

 

468,530

Accumulated deficit

 

(449,269)

 

(428,112)

Accumulated other comprehensive loss

 

(1,642)

 

(534)

Total equity attributable to XWELL, Inc.

 

19,401

 

39,926

Noncontrolling interests

 

7,869

 

8,023

Total equity

 

27,270

 

47,949

Total liabilities and equity

$

44,550

$

70,426

*Adjusted, where applicable, to reflect the impact of the 1:20 reverse stock split that became effective September 28, 2023.

The accompanying notes form an integral part of these unaudited condensed consolidated financial statements.

3

Table of Contents

XWELL, Inc. and Subsidiaries

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(Unaudited)

(In thousands, except share and per share data)

Three months ended September 30, 

Nine months ended September 30, 

    

2023

    

2022

    

2023

    

2022

    

Revenue, net

 

  

 

  

 

  

 

  

 

Patient services revenue

$

$

4,607

$

148

$

31,728

Services

6,709

5,583

20,485

15,341

Products

 

747

 

542

 

2,044

 

1,308

 

Other

12

4

29

4

Total revenue, net

 

7,468

 

10,736

 

22,706

 

48,381

 

Cost of sales

 

  

 

  

 

  

 

  

 

Labor

 

4,462

 

5,222

 

13,609

 

16,161

 

Occupancy

 

1,063

 

1,082

 

3,237

 

3,412

 

Products and other operating costs

 

852

 

3,035

 

3,057

 

17,170

 

Total cost of sales

 

6,377

 

9,339

 

19,903

 

36,743

 

Gross Profit

1,091

1,397

2,803

11,638

Depreciation and amortization

 

590

 

1,564

 

1,770

 

4,329

 

Impairment of long-lived assets

6,782

677

6,782

677

Impairment of operating lease right-of-use assets

38

38

Loss on disposal of assets

16

325

34

273

Advertising and promotion expense

313

863

628

3,696

IT/Hosting services

273

741

1,186

2,247

Other general and administrative expenses

 

3,593

 

4,843

 

13,891

 

18,250

 

Total operating expenses

 

11,567

 

9,051

 

24,291

 

29,510

 

Operating loss

 

(10,476)

 

(7,654)

 

(21,488)

 

(17,872)

 

Interest income, net

 

105

 

114

 

334

 

159

 

Foreign exchange remeasurement gain/(loss)

366

(2)

(690)

(7)

Gain on Securities, realized and unrealized

225

703

Other non-operating expense, net

 

(198)

 

(134)

 

(345)

 

(643)

 

Loss before income taxes

 

(9,978)

 

(7,676)

 

(21,486)

 

(18,363)

 

Income tax expense

 

 

(3)

 

 

(5)

 

Net loss

(9,978)

(7,679)

(21,486)

(18,368)

Net (income) loss attributable to noncontrolling interests

 

60

 

500

 

329

 

(1,012)

 

Net loss attributable to XWELL, Inc.

$

(9,918)

$

(7,179)

$

(21,157)

$

(19,380)

Net loss

$

(9,978)

$

(7,679)

$

(21,486)

$

(18,368)

Other comprehensive loss

 

(514)

 

(102)

 

(1,108)

 

(248)

Comprehensive loss

$

(10,492)

$

(7,781)

$

(22,594)

$

(18,616)

Loss per share

 

  

 

  

 

  

 

  

Basic and diluted loss per share*

$

(2.38)

$

(1.52)

$

(5.07)

$

(3.99)

Weighted-average number of shares outstanding during the period

 

  

 

  

 

  

 

  

Basic and diluted*

 

4,173,894

 

4,731,066

 

4,170,629

 

4,858,393

*Adjusted to reflect the impact of the 1:20 reverse stock split that became effective on September 28, 2023.

The accompanying notes form an integral part of these unaudited condensed consolidated financial statements.

4

Table of Contents

XWELL, Inc. and Subsidiaries

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

(Unaudited)

(In thousands, except share and per share data)

    

    

Accumulated

    

    

    

Additional

other

Total

Non-

Common stock

Treasury Stock

paid- 

Accumulated

comprehensive

Company

controlling

Total

    

Shares*

    

Amount

Shares*

    

Amount

in capital

    

deficit

    

loss

    

equity

    

interests

    

equity

December 31, 2022

4,161,613

$

42

$

468,530

$

(428,112)

$

(534)

$

39,926

$

8,023

$

47,949

Issuance of restricted stock units

6,015

Value of shares withheld to fund payroll taxes

(22)

(22)

(22)

Stock-based compensation

589

589

23

612

Net loss for the period

(5,509)

(5,509)

(320)

(5,829)

Foreign currency translation

(130)

(130)

11

(119)

March 31, 2023

4,167,628

$

42

$

$

469,097

$

(433,621)

$

(664)

$

34,854

$

7,737

$

42,591

Issuance of restricted stock units

3,297

Stock-based compensation

603

603

23

626

Distributions to noncontrolling interests

(120)

(120)

Foreign currency translation

(464)

(464)

46

(418)

Net loss for the period

(5,730)

(5,730)

51

(5,679)

June 30, 2023

4,170,925

$

42

$

$

469,700

$

(439,351)

$

(1,128)

$

29,263

$

7,737

$

37,000

Issuance of restricted stock units

3,456

Stock-based compensation

567

567

24

591

Grant of stock for services

3

3

3

Contributions from noncontrolling interests

150

150

Foreign currency translation

(514)

(514)

18

(496)

Net loss for the period

(9,918)

(9,918)

(60)

(9,978)

September 30, 2023

4,174,381

$

42

$

$

470,270

$

(449,269)

$

(1,642)

$

19,401

$

7,869

$

27,270

*Adjusted to reflect the impact of the 1:20 reverse stock split that became effective on September 28, 2023.

The accompanying notes form an integral part of these unaudited condensed consolidated financial statements.

5

Table of Contents

XWELL, Inc. and Subsidiaries

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT) (Continued)

(Unaudited)

(In thousands, except share and per share data)

    

    

    

    

    

    

Accumulated

    

    

    

Additional

other

Total

Non-

Common stock

Treasury Stock

paid- 

Accumulated

comprehensive

Company

controlling

Total

    

Shares*

    

Amount

Shares*

    

Amount

    

in capital

    

deficit

    

loss

    

equity

    

interests

    

equity

December 31, 2021

5,063,467

$

51

$

488,268

$

(395,275)

$

(312)

$

92,732

$

7,203

$

99,935

Issuance of Common Stock for acquisition

27,624

906

906

906

Vesting of restricted stock units

19,591

Value of Shares Withheld to fund payroll taxes

(73)

(73)

(73)

Stock-based compensation

1,543

1,543

1,543

Net loss for the period

(4,283)

(4,283)

1,521

(2,762)

Repurchase and retirement of common stock

(357,122)

(3)

(11,092)

(11,095)

(11,095)

Foreign currency translation

(41)

(41)

(41)

Distributions to noncontrolling interests

(824)

(824)

Contributions from noncontrolling interests

200

200

March 31, 2022

4,753,560

$

48

$

$

479,552

$

(399,558)

$

(353)

$

79,689

$

8,100

$

87,789

Vesting of restricted stock units

14,453

Grant of stock options for services

15

15

15

Stock-based compensation

771

771

549

1,320

Net loss for the period

(7,918)

(7,918)

(9)

(7,927)

Repurchase of common stock

(66,920)

(1,021)

(1,021)

(1,021)

Foreign currency translation

(105)

(105)

(105)

Distributions to noncontrolling interests

(132)

(132)

June 30, 2022

4,768,013

$

48

(66,920)

$

(1,021)

$

480,338

$

(407,476)

$

(458)

$

71,431

$

8,508

$

79,939

Vesting of restricted stock units

12,812

Grant of stock options for services

16

16

16

Contributions from noncontrolling interests

546

546

Stock-based compensation

392

392

91

483

Net loss for the period

(7,179)

(7,179)

(500)

(7,679)

Repurchase and retirement of common stock

(619,212)

(6)

66,920

1,021

(12,688)

(11,673)

(11,673)

Foreign currency translation

(102)

(102)

(3)

(105)

Distributions to noncontrolling interests

September 30, 2022

4,161,613

$

42

$

$

468,058

$

(414,655)

$

(560)

$

52,885

$

8,642

$

61,527

*Adjusted to reflect the impact of the 1:20 reverse stock split that became effective on September 28, 2023.

The accompanying notes form an integral part of these unaudited condensed consolidated financial statements.

6

Table of Contents

XWELL, Inc. and Subsidiaries

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In thousands)

Nine months ended September 30, 

    

2023

    

2022

Cash flows from operating activities

 

  

 

  

Net loss

$

(21,486)

$

(18,368)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

Depreciation and amortization

 

1,770

 

4,329

Impairment of long lived assets

 

6,782

 

715

Foreign currency remeasurement loss

690

Loss on disposal of assets

34

273

Gain on lease termination

(821)

Unrealized gain on marketable securities

(668)

Amortization of operating lease right of use asset

1,163

1,357

Stock-based compensation

 

1,832

 

3,346

Loss on equity investment

53

528

Changes in assets and liabilities:

 

 

Decrease in inventory

192

 

794

Decrease (increase) in accounts receivable

1,665

(352)

Increase in other assets, current and non-current

(336)

 

(2,265)

Increase in deferred revenue

(266)

(1,015)

Increase in other liabilities, current and non-current

(3,226)